The regulation of epidermal melanogenesis via cAMP and/or PKC signaling pathways: Insights for the development of hypopigmenting agents

Archives of Pharmacal Research

Volumn 36, Issue 7, 2013, Pages 792-801

  Lee, Ai Young ^a   Noh, Minsoo ^b  

^a Dongguk University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

cAMP; Hypopigmenting agents; Melanogenesis; PKC

Indexed keywords

ARBUTIN; AZELAIC ACID; CYCLIC AMP; ENDOTHELIN RECEPTOR; ESTROGEN RECEPTOR; GLYCOLIC ACID; HISTAMINE RECEPTOR; HYDROQUINONE; KOJIC ACID; MELANOCORTIN 1 RECEPTOR; PROTEIN KINASE C; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

HUMAN; MELANOGENESIS; PATHOGENESIS; PIGMENTATION; REVIEW; SKIN COLOR;

ANIMALS; ANTIOXIDANTS; CYCLIC AMP; EPIDERMIS; HUMANS; HYDROQUINONES; MELANINS; MELANOCYTES; PROTEIN KINASE C; RADIATION-PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TRETINOIN; ULTRAVIOLET RAYS;

EID: 84880043989     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0130-6     Document Type: Review

References (91)

1. Andersen, G. N., M. Andersen, O. Nagaeva, J. E. Wikberg, and L. Mincheva-Nilsson. 2012. Dermal melanocortin receptor rebound in diffuse systemic sclerosis after anti-TGFβ1 antibody therapy. Scandinavian Journal of Immunology 76: 478-482.
2. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
3. Asehnoune, K., D. Strassheim, S. Mitra, J. Yeol Kim, and E. Abraham. 2005. Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB. Cellular Signalling 17: 385-394.
4. Atoyan, R.Y., A.A. Sharov, M.S. Eller, A. Sargsyan, V.A. Botchkarev, and B.A. Gilchrest. 2007. Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle. Experimental Dermatology 16: 671-677.
5. Birchall, N., S.J. Orlow, T. Kupper, and J. Pawelek. 1991. Interactions between ultraviolet light and interleukin-1 on MSH binding in both mouse melanoma and human squamous carcinoma cells. Biochemical and Biophysical Research Communications 175: 839-845.
6. Birlea, S.A., G.E. Costin, and D.A. Norris. 2008. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Current Drug Targets 9: 345-359.
7. Blume-Jensen, P., G. Jiang, R. Hyman, K.F. Lee, S. O'Gorman, and T. Hunter. 2000. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nature Genetics 24: 157-162.
8. Bolognia, J., M. Murray, and J. Pawelek. 1989. UVB-induced melanogenesis may be mediated through the MSH-receptor system. Journal of Investigative Dermatology 92: 651-656.
9. Brilliant, M.H. 2001. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Research 14: 86-93.
10. Busca, R., and R. Ballotti. 2000. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Research 13: 60-69.
11. Cao, W., K.M. Harnett, J. Behar, and P. Biancani. 2000. Group I secreted PLA2 in the maintenance of human lower esophageal sphincter tone. Gastroenterology 119: 1243-1252.
12. Carsberg, C.J., J. Ohanian, and P.S. Friedmann. 1995. Ultraviolet radiation stimulates a biphasic pattern of 1,2-diacylglycerol formation in cultured human melanocytes and keratinocytes by activation of phospholipases C and D. Biochemical Journal 305: 471-477.
13. Chhajlani, V., and J.E. Wikberg. 1992. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Letters 309: 417-420.
14. Cone, R.D., D. Lu, S. Koppula, D.I. Vage, H. Klungland, B. Boston, W. Chen, D.N. Orth, C. Pouton, and R.A. Kesterson. 1996. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Progress in Hormone Research 51: 287-318.
15. Ding, H.Y., T.H. Chou, R.J. Lin, L.P. Chan, G.H. Wang, and C.H. Liang. 2011. Antioxidant and antimelanogenic behaviors of Paeonia suffruticosa. Plant Foods for Human Nutrition 66: 275-284.
16. Englaro, W., C. Bertolotto, R. Busca, A. Brunet, G. Pages, J.P. Ortonne, and R. Ballotti. 1998. Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. Journal of Biological Chemistry 273: 9966-9970.
17. Fitzgerald, L. M., J. L. Fryer, T. Dwyer, and S. M. Humphrey. 2006. Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides 27: 388-394.
18. 2+-induced differentiation in mouse epidermal keratinocytes. Inflammation Research 48(Suppl 1): S73-S74.
19. Fuller, B.B., J.B. Lunsford, and D.S. Iman. 1987. Alpha-melanocyte- stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures. Journal of Biological Chemistry 262: 4024-4033.
20. Funasaka, Y., A.K. Chakraborty, Y. Hayashi, M. Komoto, A. Ohashi, M. Nagahama, Y. Inoue, J. Pawelek, and M. Ichihashi. 1998. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. British Journal of Dermatology 139: 216-224.
21. Gilchrest, B.A., H.Y. Park, M.S. Eller, and M. Yaar. 1996. Mechanisms of ultraviolet light-induced pigmentation. Photochemistry and Photobiology 63: 1-10.
22. Ginger, R.S., S.E. Askew, R.M. Ogborne, S. Wilson, D. Ferdinando, T. Dadd, A.M. Smith, S. Kazi, R.T. Szerencsei, R.J. Winkfein, P.P. Schnetkamp, and M.R. Green. 2008. SLC24A5 encodes a trans-golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis. Journal of Biological Chemistry 283: 5486-5495.
23. Gordon, P.R., and B.A. Gilchrest. 1989. Human melanogenesis is stimulated by diacylglycerol. Journal of Investigative Dermatology 93: 700-702.
24. Guo, K., Y. Liu, H. Zhou, Z. Dai, J. Zhang, R. Sun, J. Chen, Q. Sun, W. Lu, X. Kang, and P. Chen. 2008. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion. Cancer Science 99: 486-496.
25. Hachiya, A., T. Kobayashi, Y. Takema, and G. Imokawa. 2002. Biochemical characterization of endothelin-converting enzyme-1alpha in cultured skin-derived cells and its postulated role in the stimulation of melanogenesis in human epidermis. Journal of Biological Chemistry 277: 5395-5403.
26. Hasegawa, K., R. Furuya, H. Mizuno, K. Umishio, M. Suetsugu, and K. Sato. 2010. Inhibitory effect of Elephantopus mollis H.B. and K. extract on melanogenesis in B16 murine melanoma cells by downregulating microphthalmia-associated transcription factor expression. Bioscience, Biotechnology, and Biochemistry 74: 1908-1912.
27. Hasegawa, J., Y. Goto, H. Murata, M. Takata, T. Saida, and G. Imokawa. 2008. Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin. Pigment Cell Melanoma Research 21: 687-699.
28. Hearing, V.J., and K. Tsukamoto. 1991. Enzymatic control of pigmentation in mammals. FASEB Journal 5: 2902-2909.
29. Hedley, S.J., C. Layton, M. Heaton, K.H. Chakrabarty, R.A. Dawson, D.J. Gawkrodger, and S. MacNeil. 2002. Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II. Pigment Cell Research 15: 49-56.
30. Herraiz, C., F. Journé, Z. Abdel-Malek, G. Ghanem, C. Jiménez-Cervantes, and J.C. García-Borrón. 2011. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Molecular Endocrinology 25: 138-156.
31. Higuchi, K., M. Kawashima, Y. Ichikawa, and G. Imokawa. 2003. Sphingosylphosphorylcholine is a melanogenic stimulator for human melanocytes. Pigment Cell Research 16: 670-678.
32. Hirobe, T. 2005. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Research 18: 2-12.
33. Hoth, C.F., A. Milunsky, N. Lipsky, R. Sheffer, S.K. Clarren, and C.T. Baldwin. 1993. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). American Journal of Human Genetics 52: 455-462.
34. Huber, W.E., E.R. Price, H.R. Widlund, J. Du, I.J. Davis, M. Wegner, and D.E. Fisher. 2003. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. Journal of Biological Chemistry 278: 45224-45230.
35. Imokawa, G., M. Miyagishi, and Y. Yada. 1995. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. Journal of Investigative Dermatology 105: 32-37.
36. Jeon, S., N.H. Kim, B.S. Koo, and A.Y. Lee. 2007. Bee venom stimulates human melanocyte proliferation, melanogenesis, dendricity and migration. Experimental and Molecular Medicine 39: 603-613.
37. Jeon, S., N.H. Kim, J.Y. Kim, and A.Y. Lee. 2008. Stem cell factor induces ERM protein phosphorylation through PI3K activation to mediate melanocyte proliferation and migration. Pigment Cell Melanoma Research 22: 77-85.
38. Jian, D., D. Jiang, J. Su, W. Chen, X. Hu, Y. Kuang, H. Xie, J. Li, and X. Chen. 2011. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells. Steroids 76: 1297-1304.
39. Kim, D.C., S.Y. Choi, S.H. Kim, B.S. Yun, I.D. Yoo, N.R. Reddy, H.S. Yoon, and K.T. Kim. 2006. Isoliquiritigenin selectively inhibits H(2) histamine receptor signaling. Molecular Pharmacology 70: 493-500.
40. Kim, J.Y., T.R. Lee, and A.Y. Lee. 2013. Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma. Journal of Investigative Dermatology 133: 191-200.
41. Kim, N.H., and A.Y. Lee. 2010. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival. Experimental Dermatology 19: 1073-1079.
42. Kim, N.H., K.A. Cheong, T.R. Lee, and A.Y. Lee. 2012. PDZK1 upregulation in estrogen-related hyperpigmentation in melasma. Journal of Investigative Dermatology 132: 2622-2631.
43. Lamason, R.L., M.A. Mohideen, J.R. Mest, A.C. Wong, H.L. Norton, M.C. Aros, M.J. Jurynec, X. Mao, V.R. Humphreville, J.E. Humbert, S. Sinha, J.L. Moore, P. Jagadeeswaran, W. Zhao, G. Ning, I. Makalowska, P.M. McKeigue, D. O'donnell, R. Kittles, E.J. Parra, N.J. Mangini, D.J. Grunwald, M.D. Shriver, V.A. Canfield, and K.C. Cheng. 2005. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 310: 1782-1786.
44. Lee, H.J., M.K. Park, E.J. Lee, Y.L. Kim, H.J. Kim, J.H. Kang, H.M. Kim, A.Y. Lee, and C.H. Lee. 2012. Histamine receptor 2-mediated growth- differentiation factor-15 expression is involved in histamine-induced melanogenesis. International Journal of Biochemistry and Cell Biology 44: 2124-2128.
45. Lee, S.H., T. Chen, J. Zhou, J. Hofmann, and G. Bepler. 2010. Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer. Clinical Lung Cancer 11: 169-175.
46. Leurs, R., J. Smit, and H. Timmerman. 1995. Molecular pharmacological aspects of histamine receptors. Pharmacology and Therapeutics 66: 413-463.
47. Liang, C.H. 2011. Ov-16 [4-(3,4-dihydroxybenzoyloxymethyl)phenyl-O- β-D-glucopyranoside] inhibits melanin synthesis by regulating expressions of melanogenesis-regulated gene and protein. Experimental Dermatology 20: 743-748.
48. Lynde, C.B., J.N. Kraft, and C.W. Lynde. 2006. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Letters 11: 1-6.
49. 2+ transport. Biochemical Journal 406: 365-382.
50. Martinez-Esparza, M., F. Solano, and J.C. Garcia-Borron. 1999. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cellular and Molecular Biology 45: 991-1000.
51. Mountjoy, K.G., L.S. Robbins, M. Mortrud, and R.D. Cone. 1992. The cloning of a family genes that encode melanocortin receptors. Science 257: 1248-1251.
52. Murphy, L.O., and J. Blenis. 2006. MAPK signal specificity: the right place at the right time. Trends in Biochemical Sciences 31: 268-275.
53. Na, Y.J., H.S. Baek, S.M. Ahn, H.J. Shin, I.S. Chang, and J.S. Hwang. 2007. [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs. Biochemical Pharmacology 74: 780-786.
54. Nakajima, H., Y. Wakabayashi, K. Wakamatsu, and G. Imokawa. 2011a. An extract of Melia toosendan attenuates endothelin-1-stimulated pigmentation in human epidermal equivalents through the interruption of PKC activity within melanocytes. Archives of Dermatological Research 303: 263-276.
55. Nakajima, H., Y. Wakabayashi, K. Wakamatsu, and G. Imokawa. 2011b. An extract of Withania somnifera attenuates endothelin-1-stimulated pigmentation in human epidermal equivalents through the interruption of PKC activity within melanocytes. Phytotherapy Research 25: 1398-1411.
56. Nakajima, H., K. Fukazawa, Y. Wakabayashi, K. Wakamatsu, and G. Imokawa. 2012a. Withania somnifera extract attenuates stem cell factor-stimulated pigmentation in human epidermal equivalents through interruption of ERK phosphorylation within melanocytes. Journal of Natural Medicines 66: 435-446.
57. Nakajima, H., K. Fukazawa, Y. Wakabayashi, K. Wakamatsu, K. Senda, and G. Imokawa. 2012b. Abrogating effect of a xanthophyll carotenoid astaxanthin on the stem cell factor-induced stimulation of human epidermal pigmentation. Archives of Dermatological Research 304: 803-816.
58. Park, H.Y., V. Russakovsky, S. Ohno, and B.A. Gilchrest. 1993. The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. Journal of Biological Chemistry 268: 11742-11749.
59. Park, H.Y., V. Russakovsky, Y. Ao, E. Fernandez, and B.A. Gilchrest. 1996. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Experimental Cell Research 227: 70-79.
60. Park, H.Y., and B.A. Gilchrest. 1999. Signaling pathways mediating melanogenesis. Cellular and Molecular Biology 45: 919-930.
61. Park, H.Y., J. Lee, S. González, M.A. Middelkamp-Hup, S. Kapasi, S. Peterson, and B.A. Gilchrest. 2004. Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. Journal of Investigative Dermatology 122: 159-166.
62. Park, H.Y., C. Wu, L. Yonemoto, M. Murphy-Smith, H. Wu, C.M. Stachur, and B.A. Gilchrest. 2006. MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochemical Journal 395: 571-578.
63. Pérez-Bernal, A., M.A. Muñoz-Pérez, and F. Camacho. 2000. Management of facial hyperpigmentation. American Journal of Clinical Dermatology 1: 261-268.
64. Pingault, V., N. Bondurand, K. Kuhlbrodt, D.E. Goerich, M.O. Prehu, A. Puliti, B. Herbarth, I. Hermans-Borgmeyer, E. Legius, G. Matthijs, J. Amiel, S. Lyonnet, I. Ceccherini, G. Romeo, J.C. Smith, A.P. Read, M. Wegner, and M. Goossens. 1998. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nature Genetics 18: 171-173.
65. Querfeld, C., M.A. Rizvi, T.M. Kuzel, J. Guitart, A. Rademaker, S.S. Sabharwal, N.L. Krett, and S.T. Rosen. 2006. The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. Journal of Investigative Dermatology 126: 1641-1647.
66. Robbins, L.S., J.H. Nadeau, K.R. Johnson, M.A. Kelly, L. Roselli-Rehfuss, E. Baack, K.G. Mountjoy, and R.D. Cone. 1993. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72: 827-834.
67. Saijo, K., I. Mecklenbräuker, A. Santana, M. Leitger, C. Schmedt, and A. Tarakhovsky. 2002. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. Journal of Experimental Medicine 195: 1647-1652.
68. Saito, H., K. Yasumoto, K. Takeda, K. Takahashi, H. Yamamoto, and S. Shibahara. 2003. Microphthalmia-associated transcription factor in the wnt signaling pathway. Pigment Cell Research 16: 261-265.
69. Sakai, C., M. Ollmann, T. Kobayashi, Z. Abdel-Malek, J. Muller, W.D. Vieira, G. Imokawa, G.S. Barsh, and V.J. Hearing. 1997. Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO Journal 16: 3544-3552.
70. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
71. Schallreuter, K.U., S. Hasse, H. Rokos, B. Chavan, M. Shalbaf, J.D. Spencer, and J.M. Wood. 2009. Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells. Experimental Dermatology 18: 680-688.
72. Schepsky, A., K. Bruser, G.J. Gunnarsson, J. Goodall, J.H. Hallsson, C.R. Goding, E. Steingrimsson, and A. Hecht. 2006. The microphthalmia associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Molecular and Cellular Biology 26: 8914-8927.
73. Shimoda, H., J. Tanaka, S.J. Shan, and T. Maoka. 2010. Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules. Journal of Pharmacy and Pharmacology 62: 1137-1145.
74. Shimoda, H., S.J. Shan, J. Tanaka, and T. Maoka. 2012. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways. Journal of Pharmacy and Pharmacology 64: 1165-1176.
75. Slominski, A., J. Wortsman, T. Luger, R. Paus, and S. Salomon. 2000. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiological Reviews 80: 979-1020.
76. Spry, M.L., J.C. Vanover, T. Scott, O. Abona-Ama, K. Wakamatsu, S. Ito, and J.A. D'Orazio. 2009. Prolonged treatment of fair-skinned mice with topical forskolin causes persistent tanning and UV protection. Pigment Cell Melanoma Research 22: 219-229.
77. Sriraman, V., S.R. Modi, Y. Bodenburg, L.A. Denner, and R.J. Urban. 2008. Identification of ERK and JNK as signaling mediators on protein kinase C activation in cultured granulosa cells. Molecular and Cellular Endocrinology 294: 52-60.
78. Tada, A., I. Suzuki, S. Im, M.B. Davis, J. Cornelius, G. Babcock, J.J. Nordlund, and Z.A. Abdel-Malek. 1998. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth and Differentiation 9: 575-584.
79. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M.A. Palladino Jr, and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proceedings of the National Academy of Sciences of the United States of America 88: 9292-9296.
80. Thornton, M.J., A.H. Taylor, K. Mulligan, F. Al-Azzawi, C.C. Lyon, J. O'Driscoll, and A.G. Messenger. 2003. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Experimental Dermatology 12: 181-190.
81. Tian, S., P.Y. He, J.Z. Zhang, and Z. Chen. 2012. Effect of kappa elastin on melanogenesis in A375 human melanoma cells and its related mechanism. Chinese Medical Journal (England) 125: 4088-4092.
82. Tomita, Y., K. Maeda, and H. Tagami. 1989. Mechanisms for hyperpigmentation in postinflammatory pigmentation, urticaria pigmentosa and sunburn. Dermatologica 179: 49-53.
83. Tsao, A.S., H. Kantarjian, J. Cortes, S. O'Brien, and M. Talpaz. 2003. Imatinib mesylate causes hypopigmentation in the skin. Cancer 98: 2483-2487.
84. Villareal, M.O., J. Han, K. Ikuta, and H. Isoda. 2012. Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray. Journal of Dermatological Science 67: 26-36.
85. Widlund, H.R., and D.E. Fisher. 2003. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 22: 3035-3041.
86. Wu, M., T.J. Hemesath, C.M. Takemoto, M.A. Horstmann, A.G. Wells, E.R. Price, D.Z. Fisher, and D.E. Fisher. 2000. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes and Development 14: 301-312.
87. Yamaguchi, Y., S. Itami, H. Watabe, K. Yasumoto, Z.A. Abdel-Malek, T. Kubo, F. Rouzaud, A. Tanemura, K. Yoshikawa, and V.J. Hearing. 2004. Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. Journal of Cell Biology 165: 275-285.
88. Yang, G., Y. Li, E.K. Nishimura, H. Xin, A. Zhou, Y. Guo, L. Dong, M.F. Denning, B.J. Nickoloff, and R. Cui. 2008. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Molecular Cell 32: 554-563.
89. Yasumoto, K., K. Takeda, H. Saito, K. Watanabe, K. Takahashi, and S. Shibahara. 2002. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO Journal 21: 2703-2714.
90. Yoshida, M., Y. Takahashi, and S. Inoue. 2000. Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. Journal of Investigative Dermatology 114: 334-342.
91. Yoshimasa, T., D.R. Sibley, M. Bouvier, R.J. Lefkowitz, and M.G. Caron. 1987. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation. Nature 327: 67-70.